Compare Becton Dickinson and Co (BDX) vs Beyond Meat Inc (BYND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Beyond Meat Inc — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $48.93B), while Beyond Meat Inc trades at $0.42 (market cap $268.23M). The key difference: Becton Dickinson and Co is far larger — about 182.4× Beyond Meat Inc's market cap, and Becton Dickinson and Co pays a 2.34% dividend while Beyond Meat Inc pays none. Which is the better fit depends on your goals.
| BDX | BYND | |
|---|---|---|
Market Cap | $48.93B | $268.23M |
Sector | Health | Consumer Staples |
52-Week High | $185.39 | $3.62 |
52-Week Low | $138.62 | $0.42 |
Enterprise Value | $65.03B | $508.51M |
Dividend Yield | 2.34% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX (Becton, Dickinson and Company) trades at $176.86, down 0.12% on the day, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q3 2026 revenue of $5.0 billion, up 4.4% FX-neutral, and raised full-year guidance, though margins faced pressure. Analyst sentiment is mixed with a consensus price target of $183.00, while institutional ownership remains stable amid positive news on GLP-1 therapy expansions and dividend declarations.
The stock offers steady growth potential with a 2.7% dividend yield and consistent earnings outperformance, but risks include margin compression, regulatory recalls, and high valuation multiples. Near-term resistance at $180 and support at $173 will test bullish momentum, with the current price near the consensus target suggesting limited upside without further catalysts.
BYND trades at $0.5377, up 1.93% today, but remains in a deep bearish technical trend with weak sentiment. The company reported a surprising net income of $178M in 2025 after years of losses, though revenue continues to decline. Recent Q2 2026 earnings showed a smaller loss than expected, with management focusing on international expansion and new product launches like Beyond Steak Filet to drive a turnaround.
The outlook remains challenging with declining revenue, negative operating cash flow, and heavy reliance on financing. Analyst consensus is overwhelmingly bearish with 57% sell ratings. Key risks include execution of the turnaround strategy, intense competition, and persistent cash burn. The stock presents high risk with potential reward contingent on successful business transformation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Beyond Meat Inc
Beyond Meat is a provider of plant-based meats, such as burgers, sausage, ground beef, and chicken. Unlike other vegetarian products, Beyond Meat seeks to replicate the look, cook, and taste of meat, is targeted to omnivores and vegetarians alike, and is sold in the meat case. The products are widely available across the U.S. and Canada and in 83 additional countries as well. International revenue represented 31% of 2021 sales. The firm's products are available in retail stores and the food-service channel. In 2019, before the pandemic struck, sales were evenly split between these two channels, although mix stood at 70% retail/30% food service in 2021. We think the recovery from the crisis and new deals with McDonald's and Yum Brands will return food-service sales to nearly 50% in time.
Read more on BYND →
